The Canadian Cardiovascular Society has updated guidelines relating to the management of atrial fibrillation (AF); the guidelines were published online in the Canadian Journal of Cardiology.
Small study suggests protocol could help avoid need for heart transplantation
Clinicians should be aware of this possible adverse event and monitor patients receiving concomitant drugs that may prolong the QT interval.
News, Urological Disorders
A list of medications routinely prescribed in primary care practice that should be used cautiously or avoided in patients with chronic kidney disease (CKD) was compiled in a recently published study in the Annals of Pharmacotherapy.
According to the findings of this post-hoc analysis, there appears to be a consistent clinical benefit with dapagliflozin in HFrEF patients regardless of background HF therapy.
The most common inappropriate medications included proton pump inhibitors, alpha blockers, and NSAIDs.
To identify medications with potential proarrhythmic association.
According to the authors, this is the first study to identify medications most commonly reported for a specific adverse reaction using this database.
American College of Cardiology 2013
Dronedarone use resulted in lower all-cause mortality compared with other antiarrhythmic drugs with no increased risk of cardiovascular-related deaths/ hospitalizations observed in patients with atrial fibrillation (AFib), as presented at ACC.13, the American College of Cardiology's 62nd Annual Scientific Session.
Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.